Influencer Sara Bennett has died three years after she was diagnosed with ALS. The mom of two posted about parenting and ...
Influencer Sara Bennett death was announced in January 2026, nearly three years after she was diagnosed with ALS. Rusty ...
The Ohio mother and former teacher used her final months to write lessons for her sons and to help others living with ...
New research from the University of St Andrews, the University of Copenhagen and Drexel University has developed AI ...
The FDA granted fast track status to VectorY’s VTx-002, an antibody gene therapy targeting TDP-43 protein aggregates in ALS.
At 71 years old, facing a terminal diagnosis, Colorado resident Tom Pringle has one more thing he wants to do before he dies: ...
The first patient has been dosed in a Phase 2 clinical trial testing RAG-17 in people with ALS who carry mutations in the ...
Nearly three years after being diagnosed with ALS (Amyotrophic Lateral Sclerosis), influencer Sara Bennett has announced her ...
Sara Bennett, 39, lived in motion -- teaching, leading, advocating and pouring into others until the very end.
NRG Therapeutics has dosed the first participants in its Phase I clinical trial of NRG5051, being developed as a ...
4don MSN
New ALS treatment target identified: STAUFEN-1 protein reduction protects brain cells from death
University of Utah researchers at the Pulst-Scoles Laboratory have discovered that reducing levels of the STAUFEN-1 protein ...
News-Medical.Net on MSN
ALS breakthrough: Restoring protein production in motor neuron axons
Researchers at VIB and KU Leuven have identified a molecular process that allows motor neurons to maintain protein production, a process that fails in amyotrophic lateral sclerosis (ALS).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results